Phase 1/2 study of daratumumab, lenalidomide, and dexamethasone for relapsed multiple myeloma

Torben Plesner; Hendrik-Tobias Arkenau; Peter Gimsing; Jakub Krejcik; Charlotte Lemech; Monique C. Minnema; Ulrik Lassen; Jacob P. Laubach; Antonio Palumbo; Steen Lisby; Linda Basse; Jianping Wang; A. Kate Sasser; Mary E. Guckert; Carla de Boer; Nushmia Z. Khokhar; Howard Yeh; Pamela L. Clemens; Tahamtan Ahmadi; Henk M. Lokhorst; Paul G. Richardson

doi:10.1182/blood-2016-07-726729

Phase 1/2 study of daratumumab, lenalidomide, and dexamethasone for relapsed multiple myeloma

Torben Plesner, Hendrik-Tobias Arkenau, Peter Gimsing, Jakub Krejcik, Charlotte Lemech, Monique C. Minnema, Ulrik Lassen, Jacob P. Laubach, Antonio Palumbo, Steen Lisby, Linda Basse, Jianping Wang, A. Kate Sasser, Mary E. Guckert, Carla de Boer, Nushmia Z. Khokhar, Howard Yeh, Pamela L. Clemens, Tahamtan Ahmadi, Henk M. LokhorstPaul G. Richardson

Hematology

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	1821-1828
Journal	Blood
Volume	128
Issue number	14
DOIs	https://doi.org/10.1182/blood-2016-07-726729
Publication status	Published - 6 Oct 2016

Access to Document

10.1182/blood-2016-07-726729

Cite this

Plesner, T., Arkenau, H-T., Gimsing, P., Krejcik, J., Lemech, C., Minnema, M. C., Lassen, U., Laubach, J. P., Palumbo, A., Lisby, S., Basse, L., Wang, J., Sasser, A. K., Guckert, M. E., de Boer, C., Khokhar, N. Z., Yeh, H., Clemens, P. L., Ahmadi, T., ... Richardson, P. G. (2016). Phase 1/2 study of daratumumab, lenalidomide, and dexamethasone for relapsed multiple myeloma. Blood, 128(14), 1821-1828. https://doi.org/10.1182/blood-2016-07-726729

@article{41a86af665944394a622795e7639794e,

title = "Phase 1/2 study of daratumumab, lenalidomide, and dexamethasone for relapsed multiple myeloma",

author = "Torben Plesner and Hendrik-Tobias Arkenau and Peter Gimsing and Jakub Krejcik and Charlotte Lemech and Minnema, {Monique C.} and Ulrik Lassen and Laubach, {Jacob P.} and Antonio Palumbo and Steen Lisby and Linda Basse and Jianping Wang and Sasser, {A. Kate} and Guckert, {Mary E.} and {de Boer}, Carla and Khokhar, {Nushmia Z.} and Howard Yeh and Clemens, {Pamela L.} and Tahamtan Ahmadi and Lokhorst, {Henk M.} and Richardson, {Paul G.}",

year = "2016",

month = oct,

day = "6",

doi = "10.1182/blood-2016-07-726729",

language = "English",

volume = "128",

pages = "1821--1828",

journal = "Blood",

issn = "0006-4971",

publisher = "American Society of Hematology",

number = "14",

}

Plesner, T, Arkenau, H-T, Gimsing, P, Krejcik, J, Lemech, C, Minnema, MC, Lassen, U, Laubach, JP, Palumbo, A, Lisby, S, Basse, L, Wang, J, Sasser, AK, Guckert, ME, de Boer, C, Khokhar, NZ, Yeh, H, Clemens, PL, Ahmadi, T, Lokhorst, HM & Richardson, PG 2016, 'Phase 1/2 study of daratumumab, lenalidomide, and dexamethasone for relapsed multiple myeloma', Blood, vol. 128, no. 14, pp. 1821-1828. https://doi.org/10.1182/blood-2016-07-726729

TY - JOUR

T1 - Phase 1/2 study of daratumumab, lenalidomide, and dexamethasone for relapsed multiple myeloma

AU - Plesner, Torben

AU - Arkenau, Hendrik-Tobias

AU - Gimsing, Peter

AU - Krejcik, Jakub

AU - Lemech, Charlotte

AU - Minnema, Monique C.

AU - Lassen, Ulrik

AU - Laubach, Jacob P.

AU - Palumbo, Antonio

AU - Lisby, Steen

AU - Basse, Linda

AU - Wang, Jianping

AU - Sasser, A. Kate

AU - Guckert, Mary E.

AU - de Boer, Carla

AU - Khokhar, Nushmia Z.

AU - Yeh, Howard

AU - Clemens, Pamela L.

AU - Ahmadi, Tahamtan

AU - Lokhorst, Henk M.

AU - Richardson, Paul G.

PY - 2016/10/6

Y1 - 2016/10/6

U2 - 10.1182/blood-2016-07-726729

DO - 10.1182/blood-2016-07-726729

M3 - Article

C2 - 27531679

SN - 0006-4971

VL - 128

SP - 1821

EP - 1828

JO - Blood

JF - Blood

IS - 14

ER -